curve lines
Webinar

Navigating the Path to Clinical Implementation and Future Outlook

  • Past
  • 13/02/2025 11:00 Europe/Brussels

Discover unique insights from esteemed experts in the field of Targeted Alpha Therapy, from the latest advancements in radiopharmaceutical development, through key clinical trials involving Actinium-225, to the early and upcoming trials with Astatine-211.

This webinar is already ready over. Missed the live webinar or want to rewatch it? 

Speakers

  • Prof Frederik Giesel
    Prof Dr Frederik Giesel
    Chairman of Nuclear Medicine Department, University Hospital Düsseldorf (UKD), Germany & Visiting Professor at the Osaka University, Japan
    University of Dusseldorf, Germany & Osaka University, Japan
  • Dr Hugo Levillain
    Prof Dr Hugo Levillain
    Head of R&D Medical Physics Department University Hospital Brussels; Co-director of the Radiophysics and MRI physics laboratory Faculty of Medicine ULB; Director of NuMix Center of Microscopy and Molecular Imaging (CMMI) Gosselies ULB
    University Hospital Brussels, Belgium
  • Topics
    • The New Era of Alpha Emitters in the Translation to Clinical Arena

    • Accelerate.EU, a European initiative: The INSPIRE Study on Astatine-211 Theranostics for Triple-Negative Breast Cancer

IBA Webinar Targeted Alpha Therapies